CDK Inhibition Primes for Anti-PD-L1 Treatment in Triple-Negative Breast Cancer Models (2022)

First Author: Cheung A
Attributed to:  King's College London – Confidence in Concept 2019 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/cancers14143361

PubMed Identifier: 35884422

Publication URI: http://europepmc.org/abstract/MED/35884422

Type: Journal Article/Review

Parent Publication: Cancers

Issue: 14

ISSN: 2072-6694